» Articles » PMID: 36844596

(8-Hydroxyquinoline) Gallium(III) Complex with High Antineoplastic Efficacy for Treating Colon Cancer Via Multiple Mechanisms

Overview
Journal ACS Omega
Specialty Chemistry
Date 2023 Feb 27
PMID 36844596
Authors
Affiliations
Soon will be listed here.
Abstract

A series of (8-hydroxyquinoline) gallium(III) complexes (CP--) was synthesized and characterized by single X-ray crystallography and density functional theory (DFT) calculation. The cytotoxicity of the four gallium complexes toward a human nonsmall cell lung cancer cell line (A549), human colon cancer cell line (HCT116), and human normal hepatocyte cell line (LO2) was evaluated using MTT assays. CP- exhibited excellent cytotoxicity against HCT116 cancer cells (IC = 1.2 ± 0.3 μM) and lower toxicity than cisplatin and oxaliplatin. We also evaluated the anticancer mechanism studies in cell uptake, reactive oxygen species analysis, cell cycle, wound-healing, and Western blotting assays. The results showed that CP- affected the expression of DNA-related proteins, which led to the apoptosis of cancer cells. Moreover, molecular docking tests of CP- were performed to predict other binding sites and to confirm its higher binding force to disulfide isomerase (PDI) proteins. The emissive properties of CP- suggest that this complex can be used for colon cancer diagnosis and treatment, as well as imaging. These results also provide a foundation for the development of gallium complexes as potent anticancer agents.

Citing Articles

Responsive ZIF-90 nanocomposite material: targeted delivery of 10-hydroxycamptothecine to enhance the therapeutic effect of colon cancer (HCT116) cells.

Guo J, Deng S, Zhou S, Zhou X, Du J, Zhou S RSC Med Chem. 2024; 15(8):2663-2676.

PMID: 39149092 PMC: 11324039. DOI: 10.1039/d3md00725a.


Gallium complex K6 inhibits colorectal cancer by increasing ROS levels to induce DNA damage and enhance phosphatase and tensin homolog activity.

Li W, Yang C, Cheng Z, Wu Y, Zhou S, Qi X MedComm (2020). 2024; 5(8):e665.

PMID: 39049965 PMC: 11266899. DOI: 10.1002/mco2.665.


First Gallium and Indium Crystal Structures of Curcuminoid Homoleptic Complexes: All-Different Ligand Stereochemistry and Cytotoxic Potential.

Meza-Morales W, Alvarez-Ricardo Y, Perez-Gonzalez L, Tavera-Hernandez R, Ramirez-Apan M, Toscano R Int J Mol Sci. 2023; 24(22).

PMID: 38003515 PMC: 10671313. DOI: 10.3390/ijms242216324.

References
1.
Chitambar C, Antholine W . Iron-targeting antitumor activity of gallium compounds and novel insights into triapine(®)-metal complexes. Antioxid Redox Signal. 2012; 18(8):956-72. PMC: 3557436. DOI: 10.1089/ars.2012.4880. View

2.
Di Stefano A, Frosali S, Leonini A, Ettorre A, Priora R, Cherubini Di Simplicio F . GSH depletion, protein S-glutathionylation and mitochondrial transmembrane potential hyperpolarization are early events in initiation of cell death induced by a mixture of isothiazolinones in HL60 cells. Biochim Biophys Acta. 2006; 1763(2):214-25. DOI: 10.1016/j.bbamcr.2005.12.012. View

3.
Chai J, Head-Gordon M . Long-range corrected hybrid density functionals with damped atom-atom dispersion corrections. Phys Chem Chem Phys. 2008; 10(44):6615-20. DOI: 10.1039/b810189b. View

4.
Palchaudhuri R, Hergenrother P . DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action. Curr Opin Biotechnol. 2007; 18(6):497-503. DOI: 10.1016/j.copbio.2007.09.006. View

5.
Karumban K, Muley A, Raut R, Gupta P, Giri B, Kumbhakar S . Mononuclear Co(II) polypyridyl complexes: synthesis, molecular structure, DNA binding/cleavage, radical scavenging, docking studies and anticancer activities. Dalton Trans. 2022; 51(18):7084-7099. DOI: 10.1039/d1dt04144d. View